Now Pharma Inc., a leading Indian pharmaceutical company, acknowledges the recent statements by U.S. President Donald Trump regarding the introduction of new tariffs on pharmaceuticals. The proposed tariffs aim to impose unprecedented levels of duties on pharmaceutical imports, creating uncertainty within the global pharmaceutical industry.